沙参麦冬汤加减联合化疗治疗中晚期非小细胞肺癌效果观察  

Efficacy of the Shashen Maidong decoction plus chemotherapy on non-small cell lung cancer at middle and advanced stage

作　　者：郭光爱 张玉红 

机构地区：[1]高密市人民医院,山东高密261599

出　　处：《中医临床研究》2018年第16期97-98,共2页Clinical Journal Of Chinese Medicine

摘　　要：目的:研究沙参麦冬汤加减联合化疗治疗中晚期非小细胞肺癌效果。方法:选取2015年1月-2017年1月于本院收治的50例中晚期非小细胞肺癌患者作为研究对象,将患者随机分成两组,每组25例,一组采用化疗方式进行治疗,为对照组,另一组联合沙参麦冬汤加减治疗法进行治疗,为观察组,对比分析两组患者的治疗疗效、生活质量改善情况和不良反应发生率。结果:对照组患者的治疗有效率为60%(15例),观察组的治疗有效率为88%(22例),观察组治疗有效率高于对照组(P<0.05);对照组患者治疗后生活质量评分为(68.34±10.43)分,观察组患者治疗后生活质量评分为(79.75±13.52)分,观察组生活质量评分高于对照组(P<0.05);对照组不良反应发生率为32%(8例),观察组不良反应发生率为8%(2例),对照组不良反应发生率高于观察组(P<0.05)。结论:沙参麦冬汤加减联合化疗治疗中晚期非小细胞肺癌的效果更好,可以提高病灶的稳定性,优化患者的生活质量,同时降低不良反应的发生率,该治疗方式对于中晚期非小细胞癌具有较高的治疗价值。Objective:To study the effect of the Shashen Maidong decoction(沙参麦冬汤)plus chemotherapy on non-small cell lung cancer at middle and advanced stage.Methods:50 cases were randomly divided into two groups,25 cases in each group.The control group was given chemotherapy.The observation group was given the Shashen Maidong decoction more.The curative effect,quality of life and adverse reactions were compared and analyzed in two groups.Results:The effective rate was 88%(22 cases)in the observation group,and higher than 60%(15 cases)in the control group(P<0.05).The quality of life was(79.75±13.52)in the observation group,and higher than(68.34±10.43)in the control group(P<0.05).The adverse reactions were 32%(8 cases)in the control group,and higher than 8%(2 cases)in the observation group(P<0.05).Conclusion:The Shashen Maidong decoction plus chemotherapy shows a better effect,can improve the stability of the lesion,optimize the quality of life,reduce the adverse reactions,with a high therapeutic value.

关 键 词：沙参麦冬汤加减治疗 化疗 非小细胞肺癌 

分 类 号：R256.1[医药卫生—中医内科学]